Increased Levels of Protein-methionine Sulfoxide in Plasma Correlate with a Shift from a Mild Cognitive Impairment to an Alzheimer’s Disease Stage
by Yue Deng, MSc; Brianna M. Marsh, BSc student; and [...]
Outcomes Assessment in Clinical Trials of Alzheimer’s Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs
by Holly Posner, MD, MS; Rosie Curiel, PsyD; Chris Edgar, [...]
Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer’s Disease Spectrum
by Philip D. Harvey, PhD; Stephanie Cosentino, PhD; Rosie Curiel, PhD; [...]
Differential Diagnoses: Delirium or Dementia?
by Steven Lippmann, MD, and Malathi Latha Perugula, MD The [...]
The Neuroscience Report—Vol. 43 (June 25, 2016): Medical Marijuana in Neuroscience
The latest in neuroscience—sorted and summarized for you Welcome to [...]
The Neuoroscience Report—Vol. 30 (December 14, 2015): Memory
The latest in neuroscience—sorted and summarized for you Welcome to [...]
The Neuroscience Report—Vol. 17 (August 24, 2015): Alzheimer’s Disease
Welcome to the Neuroscience Report where each week we will [...]
Recurrence of Lobar Hemorrhage: A Red Flag for Cerebral Amyloid Angiopathy-related Inflammation?
by Vaibhav Rastogi, MBBS; Lauren L. Donnangelo; Ganesh Asaithambi, MD; Sharatchandra [...]
Patient-centered Outcomes Research (PCOR): How Can We Optimize Outcomes in CNS Research?
by Mitali Wadekar, MD; Anil Sharma, MD, MBA; and Gina [...]
Clinical Implications of the New Diagnostic Guidelines for Dementia
by Edmund Howe, MD, JD Dr. Howe is Professor, Department [...]